Evidence map›Paper›PMID 37143686›Full record

ArticleFrontiers in immunology2023

The association of systemic inflammation and cognitive functions of pre-school aged children residing in a

Maritha Kasambala, Samson Mukaratirwa, Arthur Vengesai, Tariro Mduluza-Jokonya, Luxwell Jokonya, Herald Midzi, Rutendo Birri Makota, Arnold Mutemeri, Emmanuel Maziti, Bazondlile Dube-Marimbe and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 4 countries.

Maritha KasambalaSchool of Life Sciences, University of KwaZulu-Natal, Durban, South Africa.
Samson MukaratirwaSchool of Life Sciences, University of KwaZulu-Natal, Durban, South Africa.
Arthur VengesaiDepartment of Biochemistry, Faculty of Medicine and Health Sciences, Midlands State University, Gweru, Zimbabwe.
Tariro Mduluza-JokonyaDepartment of Surgery, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
Luxwell JokonyaDepartment of Surgery, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
Herald MidziSchool of Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
Rutendo Birri MakotaDepartment of Biological Sciences and Ecology, University of Zimbabwe, Harare, Zimbabwe.
Arnold MutemeriDepartment of Psychiatry, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
Emmanuel MazitiDepartment of Psychiatry, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
Bazondlile Dube-MarimbeDepartment of Psychiatry, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
Dixon ChibandaDepartment of Psychiatry, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
Francisca MutapiAshworth Laboratories, Institute for Immunology and Infection Research and Centre for Immunity, Infection and Evolution, School of Biological Sciences, University of Edinburgh, Edinburgh, United Kingdom.
Takafira MduluzaSchool of Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
University of Zimbabwe · ZWUniversity of KwaZulu-Natal · ZACentre for Immunity, Infection and Evolution · GBMidlands State University · ZWRoss University School of Veterinary Medicine · KN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cognitive function is negatively impacted by schistosomiasis and might be caused by systemic inflammation which has been hypothesized to be one of the mechanisms driving cognitive decline, This study explored the association of systemic inflammatory biomarkers; interleukin (IL)-10, IL-6, IL-17, transforming growth factor (TGF-β), tumor necrosis factor (TNF-α), C-reactive protein (CRP) and hematological parameters with cognitive performance of preschool-aged children (PSAC) from an Schistosoma haematobium endemic area. Methods: The Griffith III tool was used to measure the cognitive performance of 136 PSAC. Whole blood and sera were collected and used to quantify levels of IL-10, TNF-α, IL-6, TGF-β, IL-17 A and CRP using the enzyme-linked immunosorbent assay and hematological parameters using the hematology analyzer. Spearman correlation analysis was used to determine the relationship between each inflammatory biomarker and cognitive performance. Multivariate logistic regression analysis was used to determine whether systemic inflammation due to S. haematobium infection affected cognitive performance in PSAC. Results: Higher levels of TNF-α and IL-6, were correlated with lower performance in the Foundations of Learning domain (r = -0.30; p < 0.001 and r = -0.26; p < 0.001), respectively. Low cognitive performance in the Eye-Hand-Coordination Domain was observed in PSAC with high levels of the following inflammatory biomarkers that showed negative correlations to performance; TNF-α (r = -0.26; p < 0.001), IL-6 (r = -0.29; p < 0.001), IL-10 (r = -0.18; p < 0.04), WBC (r = -0.29; p < 0.001), neutrophils (r = -0.21; p = 0.01) and lymphocytes (r = -0.25; p = 0.003) The General Development Domain correlated with TNF-α (r = -0.28; p < 0.001) and IL-6 (r = -0.30; p < 0.001). TGF-β, L-17A and MXD had no significant correlations to performance in any of the cognitive domains. The overall general development of PSAC was negatively impacted by S. haematobium infections (OR = 7.6; p = 0.008) and (OR = 5.6; p = 0.03) where the PSAC had higher levels of TNF-α and IL-6 respectively. Conclusion: Systemic inflammation and S. haematobium infections are negatively associated with cognitive function. We recommend the inclusion of PSAC into mass drug treatment programs.

Indexed as

Schistosoma haematobiumSchistosomiasis haematobiaAnimalsBiomarkersChildChild, PreschoolCognitionC-Reactive ProteinHumansInflammationInterleukin-10Interleukin-17Interleukin-6Transforming Growth Factor betaTumor Necrosis Factor-alphaZimbabweBiomarkersC-Reactive ProteinInterleukin-10Interleukin-17Interleukin-6Transforming Growth Factor betaTumor Necrosis Factor-alphacognitive functionscytokineshematological parameterspre-school aged childrenschistosomiasissystemic inflammation

Identifiers

PMID37143686
PMCPMC10151793
OpenAlexW4366293257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.